Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney
cancer (advanced renal cell carcinoma), advanced primary liver cancer ...
Aug 15, 2016 ... Sorafenib: learn about side effects, dosage, special precautions, and more on
Apr 29, 2015 ... Read about the cancer treatment drug sorafenib, otherwise known as Nexavar,
including what it is, how it works and possible side effects.
Nov 26, 2013 ... On November 22, 2013, the Food and Drug Administration (FDA) approved
sorafenib tosylate (Nexavar<sup>®</sup> tablets, made by Bayer Healthcare ...
Jun 13, 2005 ... Absorption, The mean relative bioavailability is 38-49% for the tablet form, when
compared to an oral solution. Sorafenib reached peak plasma ...
Find patient medical information for sorafenib oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Easy to read patient leaflet for sorafenib. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Sorafenib (Nexavar) is an orally active multikinase inhibitor that is approved in
the EU for the treatment of hepatocellular carcinoma. Monotherapy with sorafenib
Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/
ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor ...
Sorafenib is a synthetic compound targeting growth signaling and angiogenesis.
Sorafenib blocks the enzyme RAF kinase, a critical component of the ...